Filing Details
- Accession Number:
- 0001968202-23-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-29 16:07:07
- Reporting Period:
- 2023-03-27
- Accepted Time:
- 2023-03-29 16:07:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585160 | E Robert Landry | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Finance Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-27 | 800 | $381.92 | 32,905 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-27 | 589 | $825.17 | 32,316 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2023-03-27 | 3,000 | $378.98 | 35,316 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-27 | 2,204 | $825.17 | 33,112 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-03-27 | 39 | $819.47 | 33,073 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-27 | 50 | $820.46 | 33,023 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-27 | 48 | $821.39 | 32,975 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-27 | 18 | $822.57 | 32,957 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-27 | 4 | $824.30 | 32,953 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-27 | 13 | $825.59 | 32,940 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-27 | 4 | $829.16 | 32,936 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-27 | 7 | $830.01 | 32,929 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-28 | 10 | $818.81 | 32,919 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-28 | 115 | $820.85 | 32,804 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-28 | 142 | $821.40 | 32,662 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-28 | 128 | $822.67 | 32,534 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-28 | 181 | $823.60 | 32,353 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-28 | 157 | $824.54 | 32,196 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-28 | 243 | $825.37 | 31,953 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-28 | 31 | $826.36 | 31,922 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-03-27 | 3,000 | $0.00 | 3,000 | $378.98 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-03-27 | 800 | $0.00 | 800 | $381.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,337 | 2027-12-12 | No | 4 | M | Direct | |
| 0 | 2026-12-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 250 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 24, 2023.
- Represents volume-weighted average price of sales of 39 shares of Company stock on March 27, 2023 at prices ranging from $819.34 to $819.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
- Represents volume-weighted average price of sales of 50 shares of Company stock on March 27, 2023 at prices ranging from $820.00 to $820.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
- Represents volume-weighted average price of sales of 48 shares of Company stock on March 27, 2023 at prices ranging from $821.02 to $821.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
- Represents volume-weighted average price of sales of 18 shares of Company stock on March 27, 2023 at prices ranging from $822.46 to $822.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
- Represents volume-weighted average price of sales of 115 shares of Company stock on March 28, 2023 at prices ranging from $820.67 to $820.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
- Represents volume-weighted average price of sales of 142 shares of Company stock on March 28, 2023 at prices ranging from $821.04 to $821.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
- Represents volume-weighted average price of sales of 128 shares of Company stock on March 28, 2023 at prices ranging from $822.21 to $822.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
- Represents volume-weighted average price of sales of 181 shares of Company stock on March 28, 2023 at prices ranging from $823.02 to $823.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
- Represents volume-weighted average price of sales of 157 shares of Company stock on March 28, 2023 at prices ranging from $824.00 to $824.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
- Represents volume-weighted average price of sales of 243 shares of Company stock on March 28, 2023 at prices ranging from $825.02 to $825.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
